
A proud year: Looking back on 2022


Keeping the patient at the heart of our research


MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)


Continuing our legacy for more than 30 years with our free memory clinics


MAC receives recognition by BritishAmerican Business (BAB) as part of Transatlantic Growth Campaign


MAC Opens US Office/Study Site

MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial


MHRA approve launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of OUD


PRESS RELEASE: Initiator Pharma reports positive Phase IIa clinical data for IPED2015 in patients w

Peter Dewland, Senior Director of Early Phase Research at MAC Clinical Research, Elected as Chair of